Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Inventiva S.A (PA: IVA)

 
IVA Technical Analysis
5
As on 27th Aug 2025 IVA SHARE Price closed @ 4.63 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 2.53 & Strong Buy for SHORT-TERM with Stoploss of 3.29 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

IVASHARE Price

Open 4.12 Change Price %
High 4.67 1 Day 0.55 13.48
Low 4.12 1 Week 0.98 26.85
Close 4.63 1 Month 1.87 67.75
Volume 663672 1 Year 1.13 32.29
52 Week High 4.03 | 52 Week Low 1.45
 
PA France Most Active Stocks
FTI 5.91 -1.66%
VIEDS 0.72 4.35%
ALRPD 0.01 0.00%
CGG 0.69 -2.82%
ORA 13.86 -0.14%
ACA 15.56 -0.58%
CS 39.92 1.55%
ALHYG 0.01 0.00%
ALTBG 2.88 %
CA 12.36 -2.37%
 
PA France Top Gainers Stocks
ALNSC 70.00 14.75%
IVA 4.63 13.48%
IVA 4.63 13.48%
ABNX 2.31 12.14%
ALIMP 0.20 11.11%
ALUCI 0.11 10.00%
2MX 7.46 8.43%
ATA 0.13 8.33%
ATA 0.13 8.33%
ATA 0.13 8.33%
 
PA France Top Losers Stocks
AKOM 4.06 -37.05%
AKOM 4.06 -37.05%
FPN 0.02 -33.33%
MLFTI 0.03 -25.00%
MLONL 0.64 -17.95%
ORP 7.90 -12.03%
MLMON 0.88 -12.00%
ALI2S 6.50 -10.34%
ALDBT 0.09 -10.00%
FALG 0.56 -8.20%
 
 
IVA
Daily Charts		 IVA
Intraday Charts		 Whats New @
Bazaartrend		 IVA
Free Analysis
 
IVA Important Levels Intraday
RESISTANCE5.69
RESISTANCE5.35
RESISTANCE5.14
RESISTANCE4.93
SUPPORT4.33
SUPPORT4.12
SUPPORT3.91
SUPPORT3.57
 
IVA Forecast August 2025
Share
4th UP Forecast6.17
3rd UP Forecast5.68
2nd UP Forecast5.37
1st UP Forecast5.07
1st DOWN Forecast4.19
2nd DOWN Forecast3.89
3rd DOWN Forecast3.58
4th DOWN Forecast3.09
 
IVA Weekly Forecast
4th UP Forecast5.48
3rd UP Forecast5.21
2nd UP Forecast5.04
1st UP Forecast4.87
1st DOWN Forecast4.39
2nd DOWN Forecast4.22
3rd DOWN Forecast4.05
4th DOWN Forecast3.78
 
IVA Forecast2025
4th UP Forecast10.87
3rd UP Forecast8.87
2nd UP Forecast7.63
1st UP Forecast6.4
1st DOWN Forecast2.86
2nd DOWN Forecast1.63
3rd DOWN Forecast0.39
4th DOWN Forecast-1.61
 
 
IVA Other Details
Segment EQ
Market Capital 503579744.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
IVA Address
IVA
 
IVA Latest News
 
Your Comments and Response on Inventiva S.A
 
IVA Business Profile
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH. The company also develops Odiparcil, which has completed Phase IIa clinical trial for the treatment of MPS VI subtype disease. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company has strategic collaboration with AbbVie for the treatment of autoimmune diseases; and Boehringer Ingelheim International GmbH for developing new treatments for idiopathic pulmonary fibrosis. Inventiva S.A. was founded in 2011 and is based in Daix, France. Address: 50 rue de Dijon, Daix, France, 21121
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service